VASCULAR BIOGENICS LTD (VBLT)
Institutional ownership reported to the SEC as of Q3 2023, across 20 quarters.
21
Reporting holders
$234.1K
Reported value
0.0%
Held as options
+7
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2023 | 21 | $234.1K | 958,850 | 8 | 0 | 3 | 0.0% |
| Q2 2023 | 14 | $147.8K | 640,522 | 3 | 1 | 2 | 0.0% |
| Q1 2023 | 13 | $129.4K | 771,950 | 2 | 1 | 5 | 0.0% |
| Q4 2022 | 18 | $156.5K | 1,281,231 | 3 | 4 | 6 | 1.5% |
| Q3 2022 | 24 | $576.6K | 3,335,208 | 11 | 6 | 4 | 10.2% |
| Q2 2022 | 32 | $12.3M | 5,927,080 | 7 | 5 | 6 | 9.5% |
| Q1 2022 | 29 | $11.5M | 6,401,776 | 5 | 7 | 5 | 6.0% |
| Q4 2021 | 29 | $16.4M | 7,735,383 | 6 | 3 | 6 | 7.2% |
| Q3 2021 | 31 | $11.2M | 4,955,270 | 7 | 2 | 11 | 9.4% |
| Q2 2021 | 27 | $10.3M | 3,834,108 | 8 | 5 | 4 | 11.1% |
| Q1 2021 | 29 | $6.5M | 2,694,454 | 14 | 4 | 6 | 17.7% |
| Q4 2020 | 20 | $6.3M | 2,011,565 | 7 | 1 | 4 | 40.0% |
| Q3 2020 | 16 | $2.5M | 1,890,449 | 2 | 4 | 4 | 7.3% |
| Q2 2020 | 22 | $3.3M | 2,500,306 | 5 | 5 | 2 | 3.3% |
| Q1 2020 | 24 | $1.8M | 1,275,454 | 9 | 4 | 4 | 7.0% |
| Q4 2019 | 19 | $1.9M | 1,531,221 | 3 | 3 | 6 | 5.5% |
| Q3 2019 | 19 | $2.4M | 1,678,404 | 3 | 1 | 6 | 5.2% |
| Q2 2019 | 19 | $5.5M | 4,151,993 | 2 | 8 | 2 | 2.1% |
| Q1 2019 | 22 | $3.9M | 2,460,053 | 6 | 3 | 5 | 3.5% |
| Q4 2018 | 26 | $5.0M | 5,022,193 | 2 | 1 | 0 | 1.9% |